NCT04667195 is a clinical trial of Clinical assessment in Acute Pyelonephritis, sponsored by University of Southern Denmark.

Who is sponsoring NCT04667195?

NCT04667195 is sponsored by University of Southern Denmark.

What drugs are being tested in NCT04667195?

Interventions in NCT04667195: Clinical assessment.

What condition does NCT04667195 study?

NCT04667195 studies Acute Pyelonephritis.

Is NCT04667195 still recruiting?

NCT04667195 is currently completed. Last updated 14 September 2022.

Last reviewed 2022-09-14 · How we verify

NCT04667195

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Characteristics of Acutely Hospitalized Adults With Acute Pyelonephritis

Completed Last updated 14 September 2022

What this trial tests

trial testing Clinical assessment in Acute Pyelonephritis in 966 participants. Completed in 1 June 2022.

Timeline

1 March 2021

Primary endpoint
28 February 2022

1 June 2022

Quick facts

Lead sponsor	University of Southern Denmark
Status	Completed
Study type	OBSERVATIONAL
Enrollment	966
Start date	1 March 2021
Primary completion	28 February 2022
Estimated completion	1 June 2022
Sites	1 location across Denmark

Drugs / interventions tested

Clinical assessment — full drug profile →

Conditions studied

Acute Pyelonephritis — all drugs for Acute Pyelonephritis →

Sponsor

University of Southern Denmark

Who can join

18 and older, any sex, with Acute Pyelonephritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute pyelonephritis is an acute infection. Today the diagnosis is made primarily on the basis of unspecific clinical symptoms with flank tenderness combined with as a key clue. This study will investigate which clinical and paraclinical characteristics available within 4 hours of hospital stay, that describes the patients admitted in the emergency department with acute pyelonephritis the best.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

Improved diagnostics of infectious diseases in emergency departments: a protocol of a multifaceted multicentre diagnostic study.
Skjøt-Arkil H, Heltborg A, Lorentzen MH, Cartuliares MB, et al · · 2021 · cited 17× · PMID 34593497 · DOI 10.1136/bmjopen-2021-049606
Urine Flow Cytometry and Dipstick Analysis in Diagnosing Bacteriuria and Urinary Tract Infections among Adults in the Emergency Department-A Diagnostic Accuracy Trial.
Hertz MA, Johansen IS, Rosenvinge FS, Brasen CL, et al · · 2024 · cited 3× · PMID 38396451 · DOI 10.3390/diagnostics14040412
The Diagnostic Accuracy of Procalcitonin, Soluble Urokinase-Type Plasminogen Activator Receptors, and C-Reactive Protein in Diagnosing Urinary Tract Infections in the Emergency Department-A Diagnostic Accuracy Study.
Hertz MA, Johansen IS, Rosenvinge FS, Brasen CL, et al · · 2024 · cited 2× · PMID 38542009 · DOI 10.3390/jcm13061776
Clinical characteristics, factors associated with urinary tract infection and outcome in acutely admitted patients with infection; an exploratory cross-sectional cohort study.
Hertz MA, Skjøt-Arkil H, Heltborg A, Lorentzen MH, et al · · 2024 · cited 1× · PMID 38984294 · DOI 10.1016/j.heliyon.2024.e32815
Prediction of infection in the emergency department-a machine learning model.
Søgaard SN, Skjøt-Arkil H, Mogensen CB, Rosenvinge FS, et al · · 2026 · PMID 42147041 · DOI 10.3389/frai.2026.1812692
Clinical characteristics and diagnostic accuracy of preliminary diagnoses in adults with infections in Danish emergency departments: a multicentre combined cross-sectional and diagnostic study.
Skjøt-Arkil H, Cartuliares MB, Heltborg A, Lorentzen MH, et al · · 2024 · PMID 39638587 · DOI 10.1136/bmjopen-2024-090259

Verify or expand the search:

Other trials of Clinical assessment

Trials testing the same drug.

NCT06997380 — Evaluation of the Safety and Efficacy of an Injectable Liposomal Gel · NA · enrolling by invitation
NCT06411028 — Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia · Phase 4 · recruiting
NCT06008704 — Pain in Parkinson's Disease: Exploration of the Serotonin System in Positron Emission Tomography (PET [18F]-MPPF) · NA · recruiting
NCT05932589 — Neurophysiologic Biomarkers in Rett Syndrome · recruiting
NCT06014697 — OCT and Invasion in Cutaneous Skin Lesions · completed

Other University of Southern Denmark trials

Trials by the same sponsor.

NCT07531290 — PeerScreen Trial - Reducing Screen Media Use in Peer-groups of Young People · NA · not yet recruiting
NCT07384273 — Evaluating the Effectiveness of an Internet-based Therapy (iCARE) to Treat Symptoms of Postpartum Depression · NA · recruiting
NCT07426679 — Should Anaesthesiologists Be Taught to Perform Ultrasound-- Assisted Neuraxial Access in Spinal Anaesthesia? · NA · recruiting
NCT07104292 — Pelvic Floor Muscle Training During Pregnancy · NA · recruiting
NCT07194759 — Health Literacy Levels of Patients Living With Type 2 Diabetes and Multi-disease and Their Families Using HLQTM · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04667195 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Southern Denmark
Last refreshed: 14 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04667195.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing